Needham Company Earns FDA Approval for Rare Disease Treatment
October 13, 2025 • After more than 10 years of work developing the drug, Stealth BioTherapeutics looks to bring Forzinity to Barth syndrome patients. In...
NPH’s New Approach to Recovery
April 18, 2024 • The Needham Public Health Division is hoping to make new in-roads to recovery through peer counseling. At their first meeting since...
